Literature DB >> 21698414

PET molecular imaging in stem cell therapy for neurological diseases.

Jiachuan Wang1, Mei Tian, Hong Zhang.   

Abstract

Human neurological diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, spinal cord injury and multiple sclerosis are caused by loss of different types of neurons and glial cells in the brain and spinal cord. At present, there are no effective therapies against these disorders. Discovery of the therapeutic potential of stem cells offers new strategies for the treatment of neurological diseases. Direct assessment of stem cells' survival, interaction with the host and impact on neuronal functions after transplantation requires advanced in vivo imaging techniques. Positron emission tomography (PET) is a potential molecular imaging modality to evaluate the viability and function of transplanted tissue or stem cells in the nervous system. This review focuses on PET molecular imaging in stem cell therapy for neurological diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21698414     DOI: 10.1007/s00259-011-1860-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  127 in total

1.  Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection.

Authors:  Didier Blocklet; Michel Toungouz; Guy Berkenboom; Micheline Lambermont; Philippe Unger; Nicolas Preumont; Eric Stoupel; Dominique Egrise; Jean-Paul Degaute; Michel Goldman; Serge Goldman
Journal:  Stem Cells       Date:  2005-10-13       Impact factor: 6.277

2.  Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action.

Authors:  Jingxiong Wang; Sui Zhang; Brian Rabinovich; Luc Bidaut; Suren Soghomonyan; Mian M Alauddin; James A Bankson; Elizabeth Shpall; James T Willerson; Juri G Gelovani; Edward T H Yeh
Journal:  Circ Res       Date:  2010-05-06       Impact factor: 17.367

3.  Neurons derived in vitro from ES cells express homeoproteins characteristic of motoneurons and interneurons.

Authors:  Y Renoncourt; P Carroll; P Filippi; V Arce; S Alonso
Journal:  Mech Dev       Date:  1998-12       Impact factor: 1.882

4.  Fetal and adult human CNS stem cells have similar molecular characteristics and developmental potential.

Authors:  K Palm; T Salin-Nordström; M F Levesque; T Neuman
Journal:  Brain Res Mol Brain Res       Date:  2000-05-31

5.  Radiolabeling and in vivo imaging of transplanted renal lineages differentiated from human embryonic stem cells in fetal rhesus monkeys.

Authors:  Alice F Tarantal; C Chang I Lee; Cynthia A Batchelder; Jared E Christensen; Daniel Prater; Simon R Cherry
Journal:  Mol Imaging Biol       Date:  2012-04       Impact factor: 3.488

6.  Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease.

Authors:  Neelam K Venkataramana; Satish K V Kumar; Sudheer Balaraju; Radhika Chemmangattu Radhakrishnan; Abhilash Bansal; Ashish Dixit; Deepthi K Rao; Madhulita Das; Majahar Jan; Pawan Kumar Gupta; Satish M Totey
Journal:  Transl Res       Date:  2009-08-06       Impact factor: 7.012

7.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

8.  Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model.

Authors:  Kiryo Wakabayashi; Atsushi Nagai; Abdullah Md Sheikh; Yuri Shiota; Dashdemberel Narantuya; Tatsuzo Watanabe; Junichi Masuda; Shotai Kobayashi; Seung U Kim; Shuhei Yamaguchi
Journal:  J Neurosci Res       Date:  2010-04       Impact factor: 4.164

9.  Directed differentiation of human-induced pluripotent stem cells generates active motor neurons.

Authors:  Saravanan Karumbayaram; Bennett G Novitch; Michaela Patterson; Joy A Umbach; Laura Richter; Anne Lindgren; Anne E Conway; Amander T Clark; Steve A Goldman; Kathrin Plath; Martina Wiedau-Pazos; Harley I Kornblum; William E Lowry
Journal:  Stem Cells       Date:  2009-04       Impact factor: 6.277

10.  Substituted 3-phenyltropane analogs of cocaine: synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging.

Authors:  P C Meltzer; A Y Liang; A L Brownell; D R Elmaleh; B K Madras
Journal:  J Med Chem       Date:  1993-04-02       Impact factor: 7.446

View more
  5 in total

1.  MRI stem cell tracking for therapy in experimental cerebral ischemia.

Authors:  Pedro Ramos-Cabrer; Mathias Hoehn
Journal:  Transl Stroke Res       Date:  2011-10-27       Impact factor: 6.829

Review 2.  Imaging of cells and nanoparticles: implications for drug delivery to the brain.

Authors:  Katica Stojanov; Inge S Zuhorn; Rudi A J O Dierckx; Erik F J de Vries
Journal:  Pharm Res       Date:  2012-07-18       Impact factor: 4.200

3.  Lineage mapping and characterization of the native progenitor population in cellular allograft.

Authors:  Mike Chen; Rahul Jandial; Josh Neman; Vincent Duenas; Claudia Kowolik; Amanda Hambrecht
Journal:  Spine J       Date:  2013-01-08       Impact factor: 4.166

Review 4.  Reporter Genes for Brain Imaging Using MRI, SPECT and PET.

Authors:  Tianxin Gao; Pei Wang; Teng Gong; Ying Zhou; Ancong Wang; Xiaoying Tang; Xiaolei Song; Yingwei Fan
Journal:  Int J Mol Sci       Date:  2022-07-30       Impact factor: 6.208

Review 5.  Development of new technologies for stem cell research.

Authors:  Xibo Ma; Qian Zhang; Xin Yang; Jie Tian
Journal:  J Biomed Biotechnol       Date:  2012-11-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.